Dexcom Stock: The diabetes play rallied to new highs this week, topping a new buy point in the wake of the FDA’s clearance of a new device.

The post Diabetes Play Dexcom Tops Buy Point After FDA Clears Device Likely To Be Used For Weight Loss appeared first on Investor’s Business Daily.